Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients

GRACEcast

English - July 31, 2016 12:00 - 4 minutes - 290 MB Video - ★★★★★ - 2 ratings
Medicine Health & Fitness Science cancer radiation cancergrace chemo chemotherapy education grace gracecast jack lung Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Using Biomarkers in Immunotherapy

Next Episode: Using Immunotherapy as First-Line Treatment and in Combinations

6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.